Literature DB >> 8229041

Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome.

F Erbguth, D Claus, A Engelhardt, D Dressler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8229041      PMCID： PMC489831          DOI： 10.1136/jnnp.56.11.1235

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic uses of botulinum toxin.

Authors:  J Jankovic; M F Brin
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

Review 2.  AAEE case report #16: Botulism.

Authors:  J B Pickett
Journal:  Muscle Nerve       Date:  1988-12       Impact factor: 3.217

3.  Stimulated single-fiber electromyography in Lambert-Eaton myasthenic syndrome.

Authors:  V Chaudhry; D F Watson; S J Bird; D R Cornblath
Journal:  Muscle Nerve       Date:  1991-12       Impact factor: 3.217

4.  Effects of botulinum neurotoxin and Lambert-Eaton myasthenic syndrome IgG at mouse nerve terminals.

Authors:  S Lande; J Black; J O Dolly; B Lang; J Newsom-Davis; D W-Wray
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1989

5.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases.

Authors:  J H O'Neill; N M Murray; J Newsom-Davis
Journal:  Brain       Date:  1988-06       Impact factor: 13.501
  5 in total
  12 in total

Review 1.  Uses of botulinum toxin injection in medicine today.

Authors:  A Münchau; K P Bhatia
Journal:  BMJ       Date:  2000-01-15

2.  Cervical Dystonia (Torticollis).

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

3.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

4.  Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.

Authors:  Takeshi Iwase; Chie Iwase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-21       Impact factor: 3.117

Review 5.  [Pharmacological aspects of therapeutic botulinum toxin preparations].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

6.  Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy.

Authors:  Louisa Kent; Paul Davies; Robin Kennett; Sunil Wimalaratna; Richard Kerr; Martin R Turner; Kevin Talbot
Journal:  J Neurol       Date:  2013-02-12       Impact factor: 4.849

7.  Clinical Pharmacology of Botulinum Toxin Drugs.

Authors:  Dirk Dressler
Journal:  Handb Exp Pharmacol       Date:  2021

Review 8.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

9.  Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.

Authors:  T Ubhi; B B Bhakta; H L Ives; V Allgar; S H Roussounis
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

10.  Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy.

Authors:  Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2010-10-16       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.